Metric Deep Dive: Understanding Caris Life Sciences Inc (CAI) Through its Ratios

Kiel Thompson

Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.

In other words, the price has increased by $0.00 from its previous closing price. On the day, 1.85 million shares were traded. CAI stock price reached its highest trading level at $27.25 during the session, while it also had its lowest trading level at $26.43.

Ratios:

Our goal is to gain a better understanding of CAI by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.36 and its Current Ratio is at 9.93. In the meantime, Its Debt-to-Equity ratio is 0.89 whereas as Long-Term Debt/Eq ratio is at 0.88.

Upgrades & Downgrades

In the most recent recommendation for this company, Canaccord Genuity on December 02, 2025, initiated with a Hold rating and assigned the stock a target price of $28.

On July 14, 2025, Wolfe Research started tracking the stock assigning a Outperform rating and target price of $32.

On July 14, 2025, TD Cowen started tracking the stock assigning a Buy rating and target price of $32.TD Cowen initiated its Buy rating on July 14, 2025, with a $32 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 11 ’25 when Power Luke Thomas sold 62,250 shares for $26.58 per share. The transaction valued at 1,654,461 led to the insider holds 99,571 shares of the business.

LUKE POWER bought 62,250 shares of CAI for $1,686,975 on Dec 11 ’25. On Nov 07 ’25, another insider, Denton John Russel, who serves as the insider of the company, bought 4,184 shares for $24.09 each. As a result, the insider paid 100,793 and bolstered with 9,184 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CAI now has a Market Capitalization of 7612323328 and an Enterprise Value of 7283569152. For the stock, the TTM Price-to-Sale (P/S) ratio is 11.73 while its Price-to-Book (P/B) ratio in mrq is 15.91. Its current Enterprise Value per Revenue stands at 11.222 whereas that against EBITDA is -137.545.

Stock Price History:

Over the past 52 weeks, CAI has reached a high of $42.50, while it has fallen to a 52-week low of $22.86. The 50-Day Moving Average of the stock is -0.83%, while the 200-Day Moving Average is calculated to be -9.54%.

Shares Statistics:

The stock has traded on average 1.64M shares per day over the past 3-months and 1696820 shares per day over the last 10 days, according to various share statistics. A total of 282.10M shares are outstanding, with a floating share count of 115.32M. Insiders hold about 59.13% of the company’s shares, while institutions hold 37.39% stake in the company. Shares short for CAI as of 1765756800 were 5434034 with a Short Ratio of 3.32, compared to 1763078400 on 5146467. Therefore, it implies a Short% of Shares Outstanding of 5434034 and a Short% of Float of 3.73.

DwinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.